Phase II study of topotecan in patients with recurrent malignant gliomaMACDONALD, D; CAIRNCROSS, G; STEWART, D et al.Annals of oncology. 1996, Vol 7, Num 2, pp 205-207, issn 0923-7534Article

Low grade glioma : A measuring radiographic response to radiotherapyBAUMAN, G; PAHAPILL, P; MACDONALD, D et al.Canadian journal of neurological sciences. 1999, Vol 26, Num 1, pp 18-22, issn 0317-1671Article

Supratentorial low-grade glioma in adults : An analysis of prognostic factors and timing of radiationLEIGHTON, C; FISHER, B; BAUMAN, G et al.Journal of clinical oncology. 1997, Vol 15, Num 4, pp 1294-1301, issn 0732-183XArticle

Lack of germ-line mutations of CDK4, p16^INK4A, and p15^INK4B in families with gliomaGAO, L; LIU, L; VAN MEYEL, D et al.Clinical cancer research. 1997, Vol 3, Num 6, pp 977-981, issn 1078-0432Article

Phase II trial of docetaxel in patients with recurrent malignant glioma : a study of the National Cancer Institute of Canada Clinical Trials GroupFORSYTH, P; CAIRNCROSS, G; STEWART, D et al.Investigational new drugs. 1996, Vol 14, Num 2, pp 203-206, issn 0167-6997Article

Pre-radiation chemotherapy for malignant glioma in adultsKIRBY, S; MACDONALD, D; FISHER, B et al.Canadian journal of neurological sciences. 1996, Vol 23, Num 2, pp 123-127, issn 0317-1671Article

Evaluating glioma therapies : Modeling treatments and predicting outcomesKIRBY, S; BROTHERS, M; IRISH, W et al.Journal of the National Cancer Institute. 1995, Vol 87, Num 24, pp 1884-1888, issn 0027-8874Article

Oligodendroglioma : An appraisal of recent data pertaining to diagnosis and treatment. CommentaryFORTIN, D; CAIRNCROSS, G. J; HAMMOND, R. R et al.Neurosurgery. 1999, Vol 45, Num 6, pp 1279-1291, issn 0148-396XArticle